Top

Published in:

01-01-2016 | Literatur kommentiert

Akuttoxizität nach hypofraktionierter versus konventionell fraktionierter Strahlentherapie bei Patienten mit Prostatakarzinom

Authors: Prof. Dr. med. Frank Lohr, Dr. med. Michael Ehmann

Published in: Strahlentherapie und Onkologie | Issue 1/2016

Auszug

Aluwini S, Pos F, Schimmel E et al (2015) Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial. Lancet Oncol16:274–283 …

Dearnaley DP, Jovic G, Syndikus I et al (2014) Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. Lancet Oncol 15:464–473PubMedCrossRef

Heemsbergen WD, Al-Mamgani A, Slot A, Dielwart MF, Lebesque JV (2014) Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival. Radiother Oncol 110:104–109PubMedCrossRef

Michalski J, Moughan J, Purdy J et al (2015) A randomized trial of 79.2 Gy versus 70.2 Gy radiation therapy (RT) for localized prostate cancer. J Clin Oncol 33:4CrossRef

Kalbasi A, Li J, Berman A et al (2015) Dose-escalated irradiation and overall survival in men with nonmetastatic prostate cancer. JAMA Oncol 1:897–906. doi:10.1001/jamaoncol.2015.2316PubMedCrossRef

Hegemann NS, Guckenberger M, Belka C et al (2014) Hypofractionated radiotherapy for prostate cancer. Rad Oncol 9:275CrossRef

Koontz BF, Bossi A, Cozzarini C et al (2015) A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer. Eur Urol 68:683–691. doi:10.1016/j.eururo.2014.08.009 PubMedCrossRef

King C, Freeman D, Kaplan I et al (2013) Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol 109:217–221PubMedCrossRef

Lukka H, Hayter C, Julian JA et al (2005) Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. Int J Clin Oncol 23:6132–6138CrossRef

Arcangeli S, Strigari L, Gomellini S et al (2012) updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 84:1172–1178PubMedCrossRef

10.

Pollack A, Walker G, Horwitz EM et al (2013) Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol 31:3860–3868PubMedPubMedCentralCrossRef

11.

Dearnaley D, Syndikus I, Sumo G et al (2012) Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial. Lancet Oncol 13:43–54PubMedCrossRef

12.

Morris J, Tyldesley S, Pai H et al (2015) ASCENDE-RT: a multicenter, randomized trial of dose-escalated external beam radiation therapy versus low-dose-rate brachytherapy for men with unfavorable-risk localized prostate cancer. J Clin Oncol 33

Title: Akuttoxizität nach hypofraktionierter versus konventionell fraktionierter Strahlentherapie bei Patienten mit Prostatakarzinom
Authors: Prof. Dr. med. Frank Lohr
Dr. med. Michael Ehmann
Publication date: 01-01-2016
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 1/2016
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-015-0924-1

At a glance: The STEP trials

Springer Medicine

Akuttoxizität nach hypofraktionierter versus konventionell fraktionierter Strahlentherapie bei Patienten mit Prostatakarzinom

Auszug

At a glance: The STEP trials

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 1/2016

Hyperfractionated stereotactic reirradiation for recurrent head and neck cancer

Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery

Hedgehog pathway inhibitor in combination with radiation therapy for basal cell carcinomas of the head and neck

Abskopale Effekte der lokalen Radiotherapie in Kombination mit systemischer Immuntherapie bei Patienten mit metastasierten soliden Tumoren

Die stereotaktische Strahlentherapie unterstützt die Immunantwort

Risk profile for osteoradionecrosis of the mandible in the IMRT era